Affinity Asset Advisors, LLC - 20 May 2025 SCHEDULE 13G/A Report for Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY)

Filing Manager: Affinity Asset Advisors, LLC
Reporting Manager: Affinity Healthcare Fund, LP
Security: Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share
Symbol: INZY
Shares outstanding: 64.6M shares
Disclosed Ownership: 1.87M shares
Ownership: 2.89%
Form type: SCHEDULE 13G/A
Filing time: 30 May 2025, 17:24:02 UTC
Date of event: 20 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Affinity Healthcare Fund, LP	2.89%	1.87M	0	1.87M	/s/ Andrew Weinstein	Andrew Weinstein
Affinity Asset Advisors, LLC	2.89%	1.87M	0	1.87M	/s/ Andrew Weinstein	Andrew Weinstein